Aerie Pharmaceuticals downgraded
April 27, 2015 at 18:46 PM EDT
Needham downgraded Aerie Pharmaceuticals Inc. (Nasdaq: AERI) from a Buy
rating to a Hold rating sending the stock price plummeting $2.17 to
close at $10.70.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.